Back

Oligomets galore!

Looking forward to carving out a couple hours to dig in.

#radonc #medonc #oligometastases

RT @CJTsaiMDPhD@twitter.com

New @IJROBP@twitter.com Oligomet Issue Part2 highlight, thanks to @sueyom@twitter.com @salma@twitter.com
- Validation of ESTRO/EORTC Oligometastasis Classification
- Prognostic factors/predictors for outcomes after SBRT
- Cost/effective analysis
- Treatment planning
- PRO
https://www.redjournal.org/issue/S0360301622X0014X?dgcid=raven_jbs_etoc_email

: https://twitter.com/CJTsaiMDPhD/status/1592212420227108869